Systemic immunoglobulin light chain amyloidosis (AL) and mutant or wild type transthyretin (ATTR) amyloidosis, account for more than 98% of the diagnosed cases with cardiac amyloidosis (3). The gene discussed is TTR; the disease is axial length measurement.